SGK1 and head and neck squamous cell carcinoma: In order to investigate whether SGK-1 inhibition attenuates the growth of head and neck squamous cell carcinoma cells, we initially treated incubated cell lines HTB41 and HTB43 for 72 hours with SGK-1 Inhibitor, and subsequently compared them to controls.